Nevirapin Viatris 400 mg Retardtabletten Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

nevirapin viatris 400 mg retardtabletten

viatris pharma gmbh - nevirapinum - retardtabletten - nevirapinum 400 mg, lactosum monohydricum 398 mg, hypromellosum, natrii stearylis fumaras, pro compresso corresp. natrium 710 µg. - l'infezione da hiv - synthetika

LOPINAVIR E RITONAVIR ACCORD Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

lopinavir e ritonavir accord

accord healthcare, s.l.u. - lopinavir e ritonavir - lopinavir e ritonavir

Copiktra Unione Europea - italiano - EMA (European Medicines Agency)

copiktra

secura bio limited - duvelisib - leukemia, lymphocytic, chronic, b-cell; lymphoma, follicular - agenti antineoplastici - copiktra monotherapy is indicated for the treatment of adult patients with: relapsed or refractory chronic lymphocytic leukaemia (cll) after at least two prior therapies.  follicular lymphoma (fl) that is refractory to at least two prior  systemic therapies.

Tivicay 5 mg Compresse per Sospensione orale Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

tivicay 5 mg compresse per sospensione orale

viiv healthcare gmbh - dolutegravirum - compresse per sospensione orale - dolutegravirum 5 mg ut dolutegravirum natricum, mannitolum, cellulosum microcristallinum, povidonum k 29-32, carboxymethylamylum natricum a, cellulosum microcristallinum silicificatum, crospovidonum, calcii sulfas dihydricus, sucralosum, aromatica, natrii stearylis fumaras, Überzug: hypromellosum, macrogolum 400, e 171 pro compresso obducto corresp. natrium 0.45 mg. - hiv-1-infektionen - synthetika

Apretude Unione Europea - italiano - EMA (European Medicines Agency)

apretude

viiv healthcare b.v. - cabotegravir - infezioni da hiv - antivirali per uso sistemico - apretude is indicated in combination with safer sex practices for pre-exposure prophylaxis (prep) to reduce the risk of sexually acquired hiv-1 infection in high-risk adults and adolescents, weighing at least 35 kg (see sections 4. 2, 4. 4 e 5.